Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1) an-label, 2 trial

de Bono, Johann S.; Mehra, Niven; Scagliotti, Giorgio, V; Castro, Elena; Dorff, Tanya; Stirling, Adam; Stenzl, Arnulf; Fleming, Mark T.; Higano, Celestia S.; Saad, Fred; Buttigliero, Consuelo; van Oort, Inge M.; Laird, A. Douglas; Mata, Marielena; Chen, Hsiang-Chun; Healy, Cynthia G.; Czibere, Akos; Fizazi, Karim

Publication services
→
Universitätsbibliographie
→
4 Medizinische Fakultät
→
View Item

« back

Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1) an-label, 2 trial

Author:

de Bono, Johann S.; Mehra, Niven; Scagliotti, Giorgio, V; Castro, Elena; Dorff, Tanya; Stirling, Adam; Stenzl, Arnulf; Fleming, Mark T.; Higano, Celestia S.; Saad, Fred; Buttigliero, Consuelo; van Oort, Inge M.; Laird, A. Douglas; Mata, Marielena; Chen, Hsiang-Chun; Healy, Cynthia G.; Czibere, Akos; Fizazi, Karim

Tübinger Autor(en):

Stenzl, Arnulf

Published in:

Lancet Oncology (2021), Bd. 22, H. 9, S. 1250-1264

Verlagsangabe:

Elsevier Science Inc

Language:

English

Full text:

http://dx.doi.org/10.1016/S1470-2045(21)00376-4

ISSN:

1474-5488